1. Signaling Pathways
  2. Others
  3. Isotope-Labeled Compounds

Isotope-Labeled Compounds

Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time. MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.

Isotope-Labeled Compounds Related Products (10876):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-W754982
    N-Cyclohexyl-1,3-benzothiazol-2-amine-13C6
    N-Cyclohexyl-1,3-benzothiazol-2-amine-13C6 (N-Cyclohexylbenzothiazole-2-amine-13C6) is the 13C-labeled N-Cyclohexyl-1,3-benzothiazol-2-amine (HY-W200757).
    N-Cyclohexyl-1,3-benzothiazol-2-amine-<sup>13</sup>C<sub>6</sub>
  • HY-B0751S
    Fumagillin-13C26
    Fumagillin-13C26 (Amebacilin-13C26) is the 13C-labeled Fumagillin (HY-B0751). Fumagillin(NSC9168) is an antimicrobial compound first isolated in 1949 from the fungus Aspergillus fumigatu. Fumagillin can inhibits HIV‐1 infection through the inhibition of HIV-1 viral protein R (Vpr) activity.
    Fumagillin-<sup>13</sup>C<sub>26</sub>
  • HY-B0161BS1
    (±)-Duloxetine-d7
    (±)-Duloxetine-d7 is deuterium labeled (±)-Duloxetine.
    (±)-Duloxetine-d<sub>7</sub>
  • HY-144180S
    Fluometuron-desmethyl-d3
    Fluometuron-desmethyl-d3 is the deuterium labeled Fluometuron-desmethyl.
    Fluometuron-desmethyl-d<sub>3</sub>
  • HY-135336BS
    (Rac)-Verapamil-d7 (hydrochloride)
    (Rac)-Verapamil-d7 (hydrochloride) is the deuterium labeled (Rac)-Verapamil.
    (Rac)-Verapamil-d<sub>7</sub> (hydrochloride)
  • HY-W746549
    (S)-4-(4-Nitrobenzyl)oxazolidin-2-one-d6
    (S)-4-(4-Nitrobenzyl)oxazolidin-2-one-d6 is the deuterium labeled (S)-4-(4-Nitrobenzyl)oxazolidin-2-one (HY-W615647).
    (S)-4-(4-Nitrobenzyl)oxazolidin-2-one-d<sub>6</sub>
  • HY-W750386
    Hydroxyprogesterone Caproate-d11
    Hydroxyprogesterone Caproate-d11 (17α-Hydroxyprogesterone hexanoate-d11; 17α-Hydroxyprogesterone caproate-d11) is the deuterium labeled Hydroxyprogesterone caproate (HY-B0742). Hydroxyprogesterone caproate is a synthetic progestin, a steroid.
    Hydroxyprogesterone Caproate-d<sub>11</sub>
  • HY-134940S1
    Quabodepistat-d4
    Quabodepistat-d4 (OPC-167832-d4) is the deuterium labeled Quabodepistat (HY-134940). Quabodepistat (OPC-167832) is a potent and orally active dprE1 inhibitor with an IC50 of 0.258 μM. Quabodepistat has antituberculosis activity and can be used for the research of tuberculosis caused by Mycobacterium tuberculosis.
    Quabodepistat-d<sub>4</sub>
  • HY-79369S
    Succinic anhydride-d4
    Succinic anhydride-d4 is the deuterium labeled Succinic anhydride. Succinic anhydride is a cyclic anhydride and a nonclaevable ADC linker extracted from patent WO2009064913A1. Succinic anhydride can react with compound 4 of the patent to link the proagent to an amine or hydroxy 1 group of a targeting polypeptide.
    Succinic anhydride-d<sub>4</sub>
  • HY-W778583
    2-Amino-3-chloro-N-hydroxy-propanamide-15N,d3
    2-Amino-3-chloro-N-hydroxy-propanamide-15N,d3 is the deuterium and 15N labeled 2-Amino-3-chloro-N-hydroxypropanamide (HY-W485575).
    2-Amino-3-chloro-N-hydroxy-propanamide-<sup>15</sup>N,d<sub>3</sub>
  • HY-W008758S1
    1-Bromododecane-d3
    98.0%
    1-Bromododecane-d3 is the deuterium labeled 1-Bromododecane.
    1-Bromododecane-d<sub>3</sub>
  • HY-144242S
    Voriconazole EP impurity D-d3
    Voriconazole EP impurity D-d3 is the deuterium labeled Voriconazole EP impurity D.
    Voriconazole EP impurity D-d<sub>3</sub>
  • HY-141934S
    2-Methylthiopurine-13C,d3
    2-Methylthiopurine-13C,d3 is the deuterium and 13C labeled 2-Methylthiopurine.
    2-Methylthiopurine-<sup>13</sup>C,d<sub>3</sub>
  • HY-W709522
    Phosphoric acid, diethyl ester-d10 sodium salt
    Phosphoric acid, diethyl ester-d10 sodium salt is the deuterium labeled Phosphoric acid, diethyl ester, sodium salt (HY-W583952).
    Phosphoric acid, diethyl ester-d<sub>10</sub> sodium salt
  • HY-W704787
    Monoethyl fumarate-d5
    Monoethyl fumarate-d5 is the deuterium labeled Monoethyl fumarate (HY-W019696). Monoethyl fumarate is the monoethyl ester form of Fumaric acid (HY-W015883). Monoethyl fumarate is the activator for Nrf2. Monoethyl fumarate is a kind of effective preservative and polymerization agent for macromolecular material.
    Monoethyl fumarate-d<sub>5</sub>
  • HY-W008816S
    Nonan-1-ol-d19
    98.0%
    n-Nonyl Alcohol-d19 is the deuterium labeled Nonan-1-ol.
    Nonan-1-ol-d<sub>19</sub>
  • HY-W746040
    (5E,9E)-Farnesylacetone-d5
    (5E,9E)-Farnesylacetone-d6 is the deuterium labeled (5E,9E)-Farnesylacetone (HY-W019824A).
    (5E,9E)-Farnesylacetone-d<sub>5</sub>
  • HY-Y0366S5
    Lauric acid-d5
    Lauric acid-d5 is the deuterium labeled Lauric acid. Lauric acid is a middle chain-free fatty acid with strong bactericidal properties. The EC50s for P. acnes, S.aureus, S. epidermidis, are 2, 6, 4 μg/mL, respectively.
    Lauric acid-d<sub>5</sub>
  • HY-W766699
    6-Amino-4-hydroxy-2-mercaptopyrimidine-13C
    6-Amino-4-hydroxy-2-mercaptopyrimidine-13C (6-Amino-2-thiouracil Monohydrate-13C) is the 13C-labeled 6-Amino-4-hydroxy-2-mercaptopyrimidine (HY-75601).
    6-Amino-4-hydroxy-2-mercaptopyrimidine-<sup>13</sup>C
  • HY-158252S
    Tiagabine-d5 (hydrochloride)
    Tiagabine-d5 (hydrochloride) is deuterium labeled Tiagabine (hydrochloride). Tiagabine hydrochloride (NO050328; NO328; TGB) is an orally active, highly selective, and reversible GAT-1 inhibitor and anticonvulsant that crosses the blood-brain barrier. By blocking the reuptake of GABA in neurons and glial cells, tiagabine increases extracellular GABA levels to enhance inhibitory signal transduction, thereby exerting multiple activities such as anticonvulsant, neuroprotective, and antioxidant effects. Tiagabine hydrochloride exhibits linear pharmacokinetic properties. Although it is metabolized by CYP3A and has a high protein binding rate, it carries a low risk of cognitive impairment. Tiagabine hydrochloride is widely used in research on related diseases including epilepsy (including refractory partial seizures), alcohol withdrawal symptoms, and Huntington's disease.
    Tiagabine-d<sub>5</sub> (hydrochloride)